Overview
Translational Advances in Cancer Prevention Agent Development (TACPAD) – 3rd Biennial Virtual Meeting
Sponsored by the Division of Cancer Prevention, NCI, NIH.
Date: October 28-30, 2024
Location: Virtual Meeting
Meeting Objectives:
The main goals of the meeting are to: 1) Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention researchers from basic and clinical research, 2) Highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials, and 3) Inform the research community of the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials and to engage cancer researchers with novel prevention concepts.
Agenda Topics:
- Plenary Session
- Molecularly Targeted Novel Agents and Emerging Technologies for Preventative Agent Development Research
- Emerging Vaccines and Immunomodulatory Agents for Cancer Prevention
- Navigating Prevention Trials: Challenges and Opportunities
- Meet-the Expert Sessions
- Meet with Program Directors
Meeting Organizers:
Mark Steven Miller, Ph.D.
Director of PREVENT Operations, Division of Cancer Prevention
Email: mark.miller5@nih.gov
Phone: 240-276-5004
Altaf Mohammed, Ph.D.
Program Director, Division of Cancer Prevention
Email: altaf.mohammed@nih.gov
Phone: 240-276-6082